Brain implant could cut seizures in Drug-Resistant epilepsy patients
NCT ID NCT07301346
First seen Jan 06, 2026 · Last updated May 14, 2026 · Updated 17 times
Summary
This study tests a device called the EASEE® System, which is implanted in the brain to stimulate areas causing seizures. The goal is to see if it safely reduces monthly seizure rates in 200 adults with drug-resistant focal epilepsy. Participants will not know if the device is active for the first 6 months, then all receive stimulation for at least a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-RESISTANT FOCAL EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.